Bio-Techne Corp (TECH): Price and Financial Metrics


Bio-Techne Corp (TECH): $79.16

-1.69 (-2.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TECH to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TECH POWR Grades

  • TECH scores best on the Quality dimension, with a Quality rank ahead of 92.58% of US stocks.
  • TECH's strongest trending metric is Stability; it's been moving down over the last 177 days.
  • TECH's current lowest rank is in the Momentum metric (where it is better than 11.34% of US stocks).

TECH Stock Summary

  • Price to trailing twelve month operating cash flow for TECH is currently 38.12, higher than 86.26% of US stocks with positive operating cash flow.
  • TECH's price/sales ratio is 11.36; that's higher than the P/S ratio of 89.43% of US stocks.
  • The volatility of BIO-TECHNE CORP's share price is greater than that of 91.47% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to TECH, based on their financial statements, market capitalization, and price volatility, are APPS, OSIS, RGEN, HZNP, and OMCL.
  • TECH's SEC filings can be seen here. And to visit BIO-TECHNE CORP's official web site, go to www.bio-techne.com.

TECH Valuation Summary

  • In comparison to the median Healthcare stock, TECH's price/earnings ratio is 91.4% higher, now standing at 42.3.
  • Over the past 243 months, TECH's EV/EBIT ratio has gone up 14.2.

Below are key valuation metrics over time for TECH.

Stock Date P/S P/B P/E EV/EBIT
TECH 2023-01-30 11.1 7.1 42.3 35.1
TECH 2023-01-27 11.4 7.3 43.6 36.2
TECH 2023-01-26 11.3 7.2 43.2 35.8
TECH 2023-01-25 11.2 7.2 42.9 35.6
TECH 2023-01-24 11.3 7.2 43.1 35.7
TECH 2023-01-23 11.6 7.4 44.2 36.7

TECH Growth Metrics

    Its 4 year revenue growth rate is now at 39.42%.
  • Its 3 year price growth rate is now at 72.33%.
  • The 3 year revenue growth rate now stands at 53.2%.
Over the past 15 months, TECH's revenue has gone up $186,503,000.

The table below shows TECH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,117.535 332.919 291.991
2022-06-30 1,105.599 325.272 272.051
2022-03-31 1,076.399 344.575 225.487
2021-12-31 1,029.575 346.313 210.53
2021-09-30 984.552 334.589 176.631
2021-06-30 931.032 352.164 140.41

TECH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TECH has a Quality Grade of B, ranking ahead of 82.49% of graded US stocks.
  • TECH's asset turnover comes in at 0.44 -- ranking 101st of 682 Pharmaceutical Products stocks.
  • URGN, TMBR, and CRIS are the stocks whose asset turnover ratios are most correlated with TECH.

The table below shows TECH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.440 0.680 0.188
2021-03-31 0.412 0.673 0.250
2020-12-31 0.392 0.666 0.240
2020-09-30 0.376 0.662 0.330
2020-06-30 0.372 0.654 0.302
2020-03-31 0.387 0.660 0.271

TECH Price Target

For more insight on analysts targets of TECH, see our TECH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $549.60 Average Broker Recommendation 1.36 (Strong Buy)

TECH Stock Price Chart Interactive Chart >

Price chart for TECH

TECH Price/Volume Stats

Current price $79.16 52-week high $113.81
Prev. close $80.85 52-week low $68.00
Day low $77.66 Volume 1,251,900
Day high $80.08 Avg. volume 1,116,561
50-day MA $82.43 Dividend yield 0.4%
200-day MA $84.72 Market Cap 12.43B

Bio-Techne Corp (TECH) Company Bio


Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company was founded in 1976 and is based in Minneapolis, Minnesota.


TECH Latest News Stream


Event/Time News Detail
Loading, please wait...

TECH Latest Social Stream


Loading social stream, please wait...

View Full TECH Social Stream

Latest TECH News From Around the Web

Below are the latest news stories about BIO-TECHNE CORP that investors may wish to consider to help them evaluate TECH as an investment opportunity.

BIO-TECHNE DECLARES DIVIDEND

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2022. The quarterly dividend will be payable February 27, 2023, to all common shareholders of record on February 13, 2023. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Yahoo | February 2, 2023

BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022.

Yahoo | February 2, 2023

BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL

Bio-Techne Corporation (NASDAQ: TECH) today announced Shane Bohnen has been appointed Senior Vice President, General Counsel effective March 3, 2023. Mr. Bohnen succeeds Brenda Furlow, who will be retiring from the Company after serving as Executive Vice President and General Counsel for the past nine years. Brenda has been and will continue to provide transition support until her March 3, 2023, retirement and will serve in a consulting capacity for special projects going forward.

Yahoo | January 31, 2023

Bio-Techne Stock: Paring Rating Back To Neutral Now (NASDAQ:TECH)

Bio-Techne endured a difficult time into the new year. Read more to see why we''re paring our rating back to neutral on TECH now.

Seeking Alpha | January 27, 2023

BIO-TECHNE LAUNCHES THE MauriceFlex™ SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS

Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of its ProteinSimple-branded MauriceFlex™ during the WCBP conference in Washington D.C. MauriceFlex™ enables protein charge variant fractionation plus routine cIEF & CE-SDS assays, making it a unique multi-functional system that further streamlines protein characterization workflows.

Yahoo | January 26, 2023

Read More 'TECH' Stories Here

TECH Price Returns

1-mo -4.07%
3-mo 0.71%
6-mo -12.14%
1-year -22.50%
3-year 56.78%
5-year 135.96%
YTD -4.49%
2022 -35.68%
2021 63.40%
2020 45.40%
2019 52.67%
2018 12.60%

TECH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TECH Dividend History

Continue Researching TECH

Want to see what other sources are saying about BIO-TECHNE Corp's financials and stock price? Try the links below:

BIO-TECHNE Corp (TECH) Stock Price | Nasdaq
BIO-TECHNE Corp (TECH) Stock Quote, History and News - Yahoo Finance
BIO-TECHNE Corp (TECH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7431 seconds.